Mather Group LLC. Acquires 23 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Mather Group LLC. raised its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 3.9% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 617 shares of the company’s stock after purchasing an additional 23 shares during the period. Mather Group LLC.’s holdings in IDEXX Laboratories were worth $312,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Nordea Investment Management AB boosted its stake in shares of IDEXX Laboratories by 15.5% in the 1st quarter. Nordea Investment Management AB now owns 13,719 shares of the company’s stock valued at $7,447,000 after purchasing an additional 1,839 shares in the last quarter. Manning & Napier Advisors LLC acquired a new position in IDEXX Laboratories during the 2nd quarter valued at about $20,418,000. First Hawaiian Bank acquired a new position in IDEXX Laboratories during the 1st quarter valued at about $982,000. Meyer Handelman Co. acquired a new stake in shares of IDEXX Laboratories in the 1st quarter valued at approximately $2,155,000. Finally, Oppenheimer Asset Management Inc. raised its position in shares of IDEXX Laboratories by 13.8% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,957 shares of the company’s stock valued at $5,825,000 after acquiring an additional 1,453 shares during the period. Institutional investors own 87.84% of the company’s stock.

IDEXX Laboratories Trading Down 0.3 %

IDXX opened at $473.28 on Friday. The stock has a market capitalization of $39.09 billion, a P/E ratio of 45.82, a P/E/G ratio of 4.32 and a beta of 1.33. IDEXX Laboratories, Inc. has a 12 month low of $372.50 and a 12 month high of $583.39. The firm’s fifty day simple moving average is $487.94 and its 200 day simple moving average is $494.71. The company has a current ratio of 1.37, a quick ratio of 1.03 and a debt-to-equity ratio of 0.33.

IDEXX Laboratories (NASDAQ:IDXX) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $2.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.88 by ($0.44). IDEXX Laboratories had a net margin of 22.34% and a return on equity of 57.03%. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the previous year, the firm posted $2.67 earnings per share. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. As a group, research analysts anticipate that IDEXX Laboratories, Inc. will post 10.45 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

IDXX has been the subject of several recent analyst reports. Stifel Nicolaus lowered their target price on shares of IDEXX Laboratories from $510.00 to $500.00 and set a “hold” rating for the company in a research note on Thursday. StockNews.com cut shares of IDEXX Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, July 10th. BTIG Research started coverage on shares of IDEXX Laboratories in a research report on Thursday, July 25th. They set a “buy” rating and a $580.00 price target on the stock. Finally, Piper Sandler reduced their price target on shares of IDEXX Laboratories from $600.00 to $520.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 14th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $581.00.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.